SpecGx, LLC 2026-01-14 Health serious FDA
Health · FDA · Recall #FDA-D-0254-2026
Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets, Rx only, SpecGx… Recall
Issued January 14, 2026 · SpecGx, LLC
In January 2026, SpecGx, LLC recalled the Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets, Rx only, SpecGx…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
What you should do
- 1 Stop using Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets, Rx only, SpecGx… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact SpecGx, LLC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- SpecGx, LLC
- Category
- Health
- Recall date
- January 14, 2026
- Units affected
- Not reported
- Sold at
- Nationwide
- Recall number
- FDA-D-0254-2026
- Made in
- United States
- Issuing agency
- FDA
In context
- SpecGx, LLC has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 356th Health recall we've logged in 2026.